Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 67 | 64 | −3 |
| Shares | 15.1M | 18.0M | +2.95M (+19.6%) |
| Value | $58.5M | $131.8M | +$73.3M (+125.4%) |
New holders (8)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| J. Goldman & Co LP | 108,000 | $790.6K | 0.04% |
| Balyasny Asset Management LLC | 65,305 | $478.0K | 0.00% |
| Jane Street Group, LLC | 10,226 | $74.9K | 0.00% |
| Two Sigma Securities, LLC | 10,042 | $73.5K | 0.00% |
| Cetera Trust Company, N.A | 1,000 | $7.32K | 0.00% |
| Russell Investments Group, Ltd. | 71 | $520 | 0.00% |
| The PNC Financial Services Group, Inc. | 12 | $88 | 0.00% |
| Cutler Group LP | 100 | $0 | 0.00% |
Sold out (11)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Caligan Partners LP | 259,593 | $1.01M |
| Boxer Capital, LLC | 166,955 | $648.6K |
| Renaissance Technologies LLC | 68,100 | $265.0K |
| Two Sigma Investments, LP | 64,558 | $250.8K |
| Millennium Management LLC | 28,321 | $110.0K |
| Jump Financial, LLC | 18,200 | $70.7K |
| Citadel Advisors LLC | 17,584 | $68.3K |
| Squarepoint Ops LLC | 16,874 | $65.6K |
| Goldman Sachs Group Inc | 13,857 | $53.8K |
| Invesco Ltd. | 10,660 | $41.4K |
| Allspring Global Investments Holdings, LLC | 6,279 | $24.4K |